Evaluation of serotypes of Staphylococcus aureus strains used in the production of a bovine mastitis bacterin

Journal of Dairy Science

Volumn 87, Issue 1, 2004, Pages 178-182

  Ma, J ^a   Cocchiaro, J ^b   Lee, J C ^b  

^a BOEHRINGER INGELHEIM VETMEDICA INC   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Bacterin; Capsule; Serotype; Staphylococcus aureus

Indexed keywords

BOS TAURUS; STAPHYLOCOCCUS AUREUS;

BACTERIAL ANTIGEN; STAPHYLOCOCCUS VACCINE;

ANIMAL; ARTICLE; CATTLE; CATTLE DISEASE; CLASSIFICATION; FEMALE; IMMUNODIFFUSION; IMMUNOLOGY; MICROBIOLOGY; SEROTYPING; STAPHYLOCOCCUS AUREUS;

ANIMALS; ANTIGENS, BACTERIAL; CATTLE; FEMALE; IMMUNODIFFUSION; MASTITIS, BOVINE; SEROTYPING; STAPHYLOCOCCAL VACCINES; STAPHYLOCOCCUS AUREUS;

EID: 1642567428     PISSN: 00220302     EISSN: None     Source Type: Journal    
DOI: 10.3168/jds.S0022-0302(04)73156-2     Document Type: Article

References (24)

1. Baddour, L. M., C. Lowrance, A. Albus, J. H. Lowrance, S. K. Anderson, and J. C. Lee. 1992. Staphylococcus aureus microcapsule expression attenuates bacterial virulence in a rat model of experimental endocarditis. J. Infect. Dis. 165:749-753.
2. Clements, M. 1998. Mastitis: Pathogens and global incidence. Pages 7-13 in Bovine Mastitis: Products and Markets. Animal Pharm Reports. Surrey, UK.
3. Guidry, A. A., A. Fattom, A. Patel, C. O'Brien, S. Shepherd, and J. Lohuis. 1998. Serotyping scheme for Staphylococcus aureus isolated from cows with mastitis. Am. J. Vet. Res. 59:1537-1539.
4. Karakawa, W. W., J. M. Fournier, W. F. Vann, R. Arbeit, R. S. Schneerson, and J. B. Robbins. 1985. Method for the serological typing of the capsular polysaccharides of Staphylococcus aureus. J. Clin. Microbiol. 22:445-447.
5. Karakawa, W. W., A. Sutton, R. Schneerson, A. Karpas, and W. F. Vann. 1988. Capsular antibodies induce type-specific phagocytosis of capsulated Staphylococcus aureus by human polymorphonuclear leukocytes. Infect. Immun. 56:1090-1095.
6. Karakawa, W. W., and W. F. Vann. 1982. Capsular polysaccharides of Staphylococcus aureus. Semin. Infect. Dis. 4:285-293.
7. Lee, C. Y. 2001a. Capsule production. Pages 35-45 in Staphylococcus aureus infection and disease. A. L. Honeyman, H. Friedman, and M. Endinelli, eds. Kluwer Academic/Plenum Publishers, New York, NY.
8. Lee, J. C. 2001b. Capsule and vaccine development. Pages 49-63 in Staphylococcus aureus infection and disease. A. L. Honeyman, H. Friedman, and M. Endinelli, eds. Kluwer Academic/Plenum Publishers, New York, NY.
9. Lee, J. C., F. Michon, N. E. Perez, C. A. Hopkins, and G. B. Pier. 1987. Chemical characterization and immunogenicity of capsular polysaccharide isolated from mucoid Staphylococcus aureus. Infect. Immun. 55:2191-2197.
10. Lee, J. C., J.-S. Park, S. E. Shepherd, V. Carey, and A. Fattom. 1997. Protective efficacy of antibodies to the Staphylococcus aureus type 5 capsular polysaccharide in a modified model of endocarditis in rats. Infect. Immun. 65:4146-4151.
11. Nickerson, S. C., W. E. Owens, G. M. Tomita, and P. W. Widel. 1999. Vaccinating dairy heifers with a S. aureus bacterin reduces mastitis at calving. Large Anim. Practice 20:16-28.
12. Novick, R. P. 1963. Properties of a cryptic high-frequency transducing phage in Staphylococcus aureus. Virology 33:155-166.
13. O'Brien, C. N., A. J. Guidry, A. Fattom, S. Shepherd, L. W. Douglass, and D.C. Westhoff. 2000. Production of antibodies to Staphylococcus aureus serotypes 5, 8, and 336 using poly(DL-lactide-co-glycolide) microspheres. J. Dairy Sci. 83:1758-1766.
14. Paape, M. J., W. P. Wergin, and A. J. Guidry. 1981. Phagocytic defense of the ruminant mammary gland. Adv. Exp. Med. Biol. 137:555-578.
15. Pankey, J. W., N. T. Boddie, L. J. Watts, and S. C. Nickerson. 1985. Evaluation of protein A and a commercial bacterin as vaccines against Staphylococcus aureus mastitis by experimental challenge. J. Dairy Sci. 68:726-731.
16. Peterson, P. K., B. J. Wilkinson, Y. Kim, D. Schmeling, and P. G. Quie. 1978. Influence of encapsulation on staphylococcal opsonization and phagocytosis by human polymorphonuclear leukocytes. Infect. Immun. 19:943-949.
17. Poutrel, B., A. Boutonnier, L. Sutra, and J. M. Fournier. 1988. Prevalence of capsular polysaccharide types 5 and 8 among Staphylococcus aureus isolates from cow, goat, and ewe milk. J. Clin. Microbiol. 26:38-40.
18. Sau, S., N. Bhasin, E. R. Wann, J. C. Lee, T. J. Foster, and C. Y. Lee. 1997. The Staphylococcus aureus allelic genetic loci for serotype 5 and 8 capsule expression contain type-specific genes flanked by common genes. Microbiology 143:2395-2405.
19. Sordelli, D. O., F. R. Buzzola, M. I. Gomez, L. Steele-Moore, D. Berg, E. Gentilini, M. Catalano, A. J. Reitz, T. Tollersrud, G. Denamiel, P. Jeric, and J. C. Lee. 2000. Capsule expression by bovine isolates of Staphylococcus aureus from Argentina: Genetic and epidemiologic analyses. J. Clin. Microbiol. 38:846-850.
20. Thakker, M., J. S. Park, V. Carey, and J. C. Lee. 1998. Staphylococcus aureus serotype 5 capsular polysaccharide is anti-phagocytic and enhances bacterial virulence in a murine bacteremia model. Infect. Immun. 66:5183-5189.
21. Tollersrud, T., K. Kenny, A. J. Reitz, and J. C. Lee. 2000. Genetic and serologic evaluation of capsule production by bovine mammary isolates of Staphylococcus aureus and other Staphylococcus spp. from Europe and the United States. J. Clin. Microbiol. 38:2998-3003.
22. Tzianabos, A. O., J. Y. Wang, and J. C. Lee. 2001. Structural rationale for the modulation of abscess formation by Staphylococcus aureus capsular polysaccharides. Proc. Natl. Acad. Sci. USA 98:9365-9370.
23. Williams, J. M., H. J. Mayerhofer, and R. W. Brown. 1966. Clinical evaluation of a Staphylococcus aureus bacterin (polyvalent somatic antigen). Vet. Med./Small Anim. Clin. 61:789-794.
24. Williams, J. M., G. R. Shipley, G. L. Smith, and D. L. Gerber. 1975. A clinical evaluation of Staphylococcus aureus bacterin in the control of staphylococcal mastitis in cows. Vet. Med./Small Anim. Clin. 70:587-594.